FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280495906> ?p ?o ?g. }

• W4280495906 endingPage "483" @default.
• W4280495906 startingPage "473" @default.
• W4280495906 abstract "The ethanol of Danshen (DEE) preparation has been widely used to treat cardiac-cerebral disease and cancer. Sweating is one of the primary processing methods of Danshen, which greatly influences its quality and pharmacological properties. Sweated and non-sweated DEE preparation combined with various synthetic drugs, add up the possibility of herbal-drug interactions.This study explored the effects of sweated and non-sweated DEE on human and rat hepatic UGT enzyme expression and activity and proposed a potential mechanism.The expression of two processed DEE on rat UGT1A, UGT2B, and nuclear receptors, including pregnane X receptor (PXR), constitutive androstane receptor (CAR), and peroxisome proliferator-activated receptor α (PPARα), were investigated after intragastric administration in rats by Western blot. Enzyme activity of DEE and its active ingredients (Tanshinone I, Cryptotanshinone, and Tanshinone I) on UGT isoenzymes was evaluated by quantifying probe substrate metabolism and metabolite formation in vitro using Ultra Performance Liquid Chromatography.The two processed DEE (5.40 g/kg) improved UGT1A (P<0.01) and UGT2B (P<0.05) protein expression, and the non-sweated DEE (2.70 g/kg) upregulated UGT2B expression protein (P<0.05), compared with the CMCNa group. On day 28, UGT1A protein expression was increased (P<0.05) both in two processed DEE groups meanwhile, the non-sweated DEE significantly enhanced UGT2B protein expression (P<0.05) on day 21, compared with the CMCNa group. The process underlying this mechanism involved the activation of nuclear receptors CAR, PXR, and PPARα. In vitro, sweated DEE (0-80 μg/mL) significantly inhibited the activity of human UGT1A7 (P<0.05) and rat UGT1A1, 1A8, and 1A9 (P<0.05). Non-sweated DEE (0-80 μg/mL) dramatically suppressed the activity of human UGT1A1, 1A3, 1A6, 1A7, 2B4, and 2B15, and rat UGT1A1, 1A3, 1A7, and 1A9 (P<0.05). Tanshinone I (0-1 μM) inhibited the activity of human UGT1A3, 1A6, and 1A7 (P<0.01) and rat UGT1A3, 1A6, 1A7, and 1A8 (P<0.05). Cryptotanshinone (0-1 μM) remarkably inhibited the activity of human UGT1A3 and 1A7 (P<0.05) and rat UGT1A7, 1A8, and 1A9 (P<0.05). Nonetheless, Tanshinone IIA (0-2 μM) is not a potent UGT inhibitor both in humans and rats. Additionally, there existed significant differences between two processed DEE in the expression of PXR, and the activity of human UGT1A1, 1A3, 1A6, and 2B15 and rat UGT1A3, and 2B15 (P<0.05).The effects of two processed DEE on hepatic UGT enzyme expression and activity differed. Accordingly, the combined usage of related UGTs substrates with DEE and its monomer components preparations may call for caution, depending on the drug's exposure-response relationship and dose adjustment. Besides, it is vital to pay attention to the distinction between sweated and non-sweated Danshen in clinic, which influences its pharmacological activity." @default.
• W4280495906 created "2022-05-22" @default.
• W4280495906 creator A5011102119 @default.
• W4280495906 creator A5024584263 @default.
• W4280495906 creator A5027438427 @default.
• W4280495906 creator A5035108785 @default.
• W4280495906 creator A5049346457 @default.
• W4280495906 creator A5073216396 @default.
• W4280495906 creator A5081692736 @default.
• W4280495906 creator A5085352453 @default.
• W4280495906 creator A5087670690 @default.
• W4280495906 date "2022-05-01" @default.
• W4280495906 modified "2023-10-16" @default.
• W4280495906 title "Comparison of Sweated and Non-Sweated Ethanol Extracts of Salvia miltiorrhiza Bge. (Danshen) Effects on Human and Rat Hepatic UDP-Glucuronosyltransferase and Preclinic Herb-Drug Interaction Potential Evaluation" @default.
• W4280495906 cites W1558671091 @default.
• W4280495906 cites W1971325740 @default.
• W4280495906 cites W1977435722 @default.
• W4280495906 cites W1983749645 @default.
• W4280495906 cites W1985410301 @default.
• W4280495906 cites W2003778114 @default.
• W4280495906 cites W2010019032 @default.
• W4280495906 cites W2021256429 @default.
• W4280495906 cites W2028211844 @default.
• W4280495906 cites W2039247749 @default.
• W4280495906 cites W2046515072 @default.
• W4280495906 cites W2049391383 @default.
• W4280495906 cites W2094329689 @default.
• W4280495906 cites W2108230265 @default.
• W4280495906 cites W2139911664 @default.
• W4280495906 cites W2140620734 @default.
• W4280495906 cites W2144863555 @default.
• W4280495906 cites W2147820242 @default.
• W4280495906 cites W2150797190 @default.
• W4280495906 cites W2157501385 @default.
• W4280495906 cites W2160021379 @default.
• W4280495906 cites W2172084602 @default.
• W4280495906 cites W2288239617 @default.
• W4280495906 cites W2579414183 @default.
• W4280495906 cites W2606992120 @default.
• W4280495906 cites W2611177400 @default.
• W4280495906 cites W2761057984 @default.
• W4280495906 cites W2791055986 @default.
• W4280495906 cites W2791605535 @default.
• W4280495906 cites W2793246122 @default.
• W4280495906 cites W2793433885 @default.
• W4280495906 cites W2799452674 @default.
• W4280495906 cites W2978000113 @default.
• W4280495906 cites W3104446445 @default.
• W4280495906 doi "https://doi.org/10.2174/1389200223666220517115845" @default.
• W4280495906 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35585828" @default.
• W4280495906 hasPublicationYear "2022" @default.
• W4280495906 type Work @default.
• W4280495906 citedByCount "0" @default.
• W4280495906 crossrefType "journal-article" @default.
• W4280495906 hasAuthorship W4280495906A5011102119 @default.
• W4280495906 hasAuthorship W4280495906A5024584263 @default.
• W4280495906 hasAuthorship W4280495906A5027438427 @default.
• W4280495906 hasAuthorship W4280495906A5035108785 @default.
• W4280495906 hasAuthorship W4280495906A5049346457 @default.
• W4280495906 hasAuthorship W4280495906A5073216396 @default.
• W4280495906 hasAuthorship W4280495906A5081692736 @default.
• W4280495906 hasAuthorship W4280495906A5085352453 @default.
• W4280495906 hasAuthorship W4280495906A5087670690 @default.
• W4280495906 hasConcept C104317684 @default.
• W4280495906 hasConcept C132040763 @default.
• W4280495906 hasConcept C170493617 @default.
• W4280495906 hasConcept C185592680 @default.
• W4280495906 hasConcept C187345961 @default.
• W4280495906 hasConcept C193264327 @default.
• W4280495906 hasConcept C2776415932 @default.
• W4280495906 hasConcept C2777477808 @default.
• W4280495906 hasConcept C2777567352 @default.
• W4280495906 hasConcept C2780655410 @default.
• W4280495906 hasConcept C55493867 @default.
• W4280495906 hasConcept C63932345 @default.
• W4280495906 hasConcept C71240020 @default.
• W4280495906 hasConcept C71924100 @default.
• W4280495906 hasConcept C86339819 @default.
• W4280495906 hasConcept C98274493 @default.
• W4280495906 hasConceptScore W4280495906C104317684 @default.
• W4280495906 hasConceptScore W4280495906C132040763 @default.
• W4280495906 hasConceptScore W4280495906C170493617 @default.
• W4280495906 hasConceptScore W4280495906C185592680 @default.
• W4280495906 hasConceptScore W4280495906C187345961 @default.
• W4280495906 hasConceptScore W4280495906C193264327 @default.
• W4280495906 hasConceptScore W4280495906C2776415932 @default.
• W4280495906 hasConceptScore W4280495906C2777477808 @default.
• W4280495906 hasConceptScore W4280495906C2777567352 @default.
• W4280495906 hasConceptScore W4280495906C2780655410 @default.
• W4280495906 hasConceptScore W4280495906C55493867 @default.
• W4280495906 hasConceptScore W4280495906C63932345 @default.
• W4280495906 hasConceptScore W4280495906C71240020 @default.
• W4280495906 hasConceptScore W4280495906C71924100 @default.
• W4280495906 hasConceptScore W4280495906C86339819 @default.
• W4280495906 hasConceptScore W4280495906C98274493 @default.
• W4280495906 hasFunder F4320334897 @default.
• W4280495906 hasFunder F4320335406 @default.
• W4280495906 hasFunder F4320335777 @default.

• next